FDA Genetic Test Oversight Is On The Rise, But How Far Can It Go?
This article was originally published in The Gray Sheet
Executive Summary
It looks increasingly likely that FDA will play a larger role in genetic test oversight, though policymakers may soon have to decide just how much more the agency can and should do